CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 62 | -29.5% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 88 | -31.2% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 128 | +172.3% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 47 | -59.1% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 115 | +11.7% | 0.00% | – |
| Q1 2021 | $2,000 | – | 103 | +442.1% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 19 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $159,000 | – | 9,186 | +61140.0% | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 15 | -97.5% | 0.00% | -100.0% |
| Q4 2018 | $8,000 | +14.3% | 610 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -100.0% | 467 | -68.1% | 0.00% | -50.0% |
| Q2 2018 | $22,998,000 | +69590.9% | 1,463 | -26.4% | 0.00% | -33.3% |
| Q1 2018 | $33,000 | -23.3% | 1,987 | -17.6% | 0.00% | -25.0% |
| Q4 2017 | $43,000 | +152.9% | 2,411 | +172.1% | 0.00% | +100.0% |
| Q3 2017 | $17,000 | +750.0% | 886 | +430.5% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 167 | +21.9% | 0.00% | – |
| Q1 2017 | $2,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |